Trace Biosciences Inc.

Beaverton, OR

UEI
YGDTEJXJC9G8
CAGE
9HEB7
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1800 NW 167th Pl #160, Beaverton, OR 97006, USA
Website
trace-bio.com
Founded
2019
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

About Trace Biosciences Inc.

Trace Biosciences Inc. is a corporate for-profit entity registered to receive federal awards. It appears to specialize in research and development of fluorescent imaging agents and technologies for medical and surgical applications.

Trace Biosciences Inc. has received prime federal contract awards from agencies like the Department of Health and Human Services' National Institutes of Health. A notable $4.1 million firm fixed price contract awarded in 2023 is for research and development related to ARPA-H SBIR Phase II Topic 04 concerning intra-operative contrast agents. This contract is associated with the Advanced Research Project Agency for Health's Small Business Innovation Research program solicitation seeking health technology proposals with commercialization potential. It runs through 2027 and is designated for total small businesses, with performance in Portland, Oregon.

Trace Biosciences Inc. has also received prime federal grant awards from agencies like the National Institutes of Health (NIH) National Cancer Institute. A $386,211 Project Grant in 2023 funds development of a two-color near-infrared fluorescence guided surgery tool for visualizing cancer margins and nerves during head and neck squamous cell carcinoma resection. Another major $2 million Project Grant awarded in 2021 supports clinical translation of the company's near-infrared nerve-specific fluorophores for nerve-sparing prostatectomy procedures. The goals involve pharmacology, toxicology, and regulatory studies to advance these imaging agents towards first-in-human trials and commercialization through industry partnerships.

Quick answers

What is Trace Biosciences Inc.'s UEI?

Trace Biosciences Inc.'s Unique Entity ID (UEI) in SAM.gov is YGDTEJXJC9G8.

What is Trace Biosciences Inc.'s CAGE code?

Trace Biosciences Inc.'s CAGE code is 9HEB7.

What is Trace Biosciences Inc.'s primary NAICS code?

Trace Biosciences Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Trace Biosciences Inc. located?

Trace Biosciences Inc.'s physical address in SAM.gov is 1800 NW 167th Pl #160, Beaverton, OR 97006, USA.

Is Trace Biosciences Inc. registered in SAM.gov?

Yes. Trace Biosciences Inc.'s SAM.gov registration is active through September 4, 2027.

What is Trace Biosciences Inc.'s most recent federal award?

Trace Biosciences Inc.'s most recent federal grant award is Molecular imaging of peripheral and central nervous system myelin - project summary demyelinating neurodegenerative… (R44NS147800), from National Institute of Neurological Disorders and Stroke, on September 3, 2026.

On GovTribe

See Trace Biosciences Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors